November 19,2018 Product News PDF New center will be a hub to identify and accelerate fresh solutions to rethink drug development and manufacturing Labs in the new facility, together with funding, will enable projects in collaboration with Israeli talent in academia, medical institutions and early-stage innovative companies Haifa (IL), 19 November 2018 – Lonza Pharma &... Read more
Sartorius Stedim Biotech will continue to offer Lonza media and buffer products but under a non-exclusive agreement Lonza selects Sartorius Stedim Biotech as preferred supplier for equipment and consumables Aubagne, November 15, 2018 – Sartorius Stedim Biotech (SSB), a leading international supplier of the biopharmaceutical industry, and Lonza announced today that they have modified their current... Read more
November 01, 2018 News Release PDF Basel (CH) and Los Angeles, CA (USA), 1 November 2018 – Lonza and Platinum Equity jointly announced today that Platinum Equity has entered into a definitive agreement with Lonza to acquire Lonza’s Water Care business and operations for USD 630 million. The inclusion of the French business in this transaction is still... Read more
October 19,2018 Product News PDF Walkersville, MD (USA) / Basel (CH), 19 October 2018– Lonza will unveil its next-generation electronic batch record execution platform, the MODA-ES™ Software Platform, at the Cell & Gene Therapy Manufacturing Forum from 13-15 November 2018, in London (UK). Building on Lonza’s extensive informatics know-how and vast experience as a contract manufacturing... Read more
Cologne (DE)/Walkersville, MD (USA), 6 September 2018 – Today, Lonza announced the release of a new technical note that provides toxicity, wound healing and cosmetic researchers with a faster method for constructing three-dimensional (3D) full-thickness skin models that closely resemble native skin. Compared with its two-dimensional (2D) counterpart, 3D cell culture is increasingly being recognized... Read more
Walkersville, MD (USA)/Basel (CH), 3 September 2018 – Lonza will reveal its next-generation endotoxin automation solution, PyroTec™ Pro Robotic Solution at the Parenteral Drug Association (PDA) Global Conference on Pharmaceutical Microbiology from 15-16 October, in Bethesda, MD (USA). At Booth #308 Lonza experts will demonstrate how the company’s instruments, reagents and software are integrated into... Read more
Cologne, Germany / Basel, Switzerland, 2 July 2018 – Lonza Bioscience is inviting visitors to explore its new dedicated website: bioscience.lonza.com. Filled with detailed application and product information, the website has been designed to support the work of scientists across the bioresearch, drug discovery and pharmaceutical manufacturing fields. Not only is the new website user friendly and mobile... Read more
Cologne (DE) / Walkersville, MD (USA), 15 June 2018 – On 25 June 2018, Lonza, in collaboration with Kirkstall Ltd., a biotechnology company based in Rotherham (UK), is hosting a free 60-minute webinar on the development of more physiologically relevant 3D lung-immune cell models for enhanced disease modeling. Conventional in vitro lung models often involve... Read more
Cologne (DE) and Wageningen (NL) 04 June 2018 – Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of endotoxin products, services and software and provides pharmaceutical testing professionals with a comprehensive set of quality control (QC) tools. Under the agreement, Lonza... Read more